These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2630 related articles for article (PubMed ID: 2753057)

  • 21. Relation between the inhibition of aggregation and the concentration of cAMP in human and rat platelets.
    Michel H; Caen JP; Born GV; Miller R; D'Auriac GA; Meyer P
    Br J Haematol; 1976 May; 33(1):27-38. PubMed ID: 178342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interruption of tumor-associated platelet consumption with platelet enzyme inhibitors.
    Slichter SJ; Weiden PL; O'Donnell MR; Storb R
    Blood; 1982 Jun; 59(6):1252-8. PubMed ID: 6805531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in anatomical distribution of tumour lesions induced by platelet-active drugs.
    Willmott N; Malcolm A; McLeod T; Gracie A; Calman KC
    Invasion Metastasis; 1983; 3(1):32-51. PubMed ID: 6677619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.
    Mills DC; Smith JB
    Biochem J; 1971 Jan; 121(2):185-96. PubMed ID: 4330088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
    Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autolymphocyte therapy. II. Dependence of in vivo anti-tumor specificity and long-term immunity against murine melanoma and carcinoma on ex vivo activated donor memory T-cells.
    Gold JE; Osband ME
    Clin Immunol Immunopathol; 1994 Jun; 71(3):325-32. PubMed ID: 7911078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors.
    Mamytbeková A; Rezábek K; Kacerovská H; Grimová J; Svobodová J
    Neoplasma; 1986; 33(4):417-21. PubMed ID: 3762804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.
    Shimamura M; Nagasawa H; Ashino H; Yamamoto Y; Hazato T; Uto Y; Hori H; Inayama S
    Br J Cancer; 2003 Jan; 88(2):307-13. PubMed ID: 12610518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Modification of metastasis formation by inhibition of platelet aggregation. Experimental and clinical results].
    Gastpar H
    Laryngol Rhinol Otol (Stuttg); 1983 Dec; 62(12):578-85. PubMed ID: 6369051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of mopidamol on survival in carcinoma of the lung and colon: final report of Veterans Administration Cooperative Study No. 188.
    Zacharski LR; Moritz TE; Baczek LA; Rickles FR; Edwards RL; Forman WB; Forcier RJ; Cornell CJ; Haakenson CM; Ballard HS
    J Natl Cancer Inst; 1988 Mar; 80(2):90-7. PubMed ID: 2830407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel function of Oncostatin M as a potent tumour-promoting agent in lung.
    Lauber S; Wong S; Cutz JC; Tanaka M; Barra N; Lhoták S; Ashkar A; Richards CD
    Int J Cancer; 2015 Feb; 136(4):831-43. PubMed ID: 24976180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mopidamol.
    J Natl Cancer Inst; 1988 Jun; 80(7):532-4. PubMed ID: 2835491
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug treatments for metastasis of the Lewis lung carcinoma: lack of correlation between inhibition of lung metastasis and survival.
    Merriman RL; Shackelford KA; Tanzer LR; Campbell JB; Bemis KG; Matsumoto K
    Cancer Res; 1989 Aug; 49(16):4509-16. PubMed ID: 2743339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of animal tumours and their metastases with 4-hydroxyanisole.
    Kanclerz A; Chapman JD
    Br J Cancer; 1986 Oct; 54(4):693-8. PubMed ID: 3778809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of a novel platinum compound--cis-dichloro (dimethylsulphoxide) (1-beta-D-rybofuranosyl-1,2,4-triazolo-3-arboxyamide) platinum (II)--"Pt-rib-1"--on cell cycle and apoptosis in ClS91 and B16 mouse melanoma in vitro.
    Drewa T; Olszewska-Słonina D; Woźniak A; Styczyński J; Drewa G; Szłyk E; Lakomska I; Kobe J; Czajkowski R
    Acta Pol Pharm; 2004; 61(1):39-44. PubMed ID: 15259856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrest.
    Es-saady D; Simon A; Ollier M; Maurizis JC; Chulia AJ; Delage C
    Cancer Lett; 1996 Sep; 106(2):193-7. PubMed ID: 8844972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mopidamol in non-small cell lung cancer: anti-oncogene or accident?
    Livingston RB
    J Natl Cancer Inst; 1988 Mar; 80(2):77-8. PubMed ID: 2830406
    [No Abstract]   [Full Text] [Related]  

  • 38. Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells.
    Smith PJ; Souès S; Gottlieb T; Falk SJ; Watson JV; Osborne RJ; Bleehen NM
    Br J Cancer; 1994 Nov; 70(5):914-21. PubMed ID: 7947097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flat revertant inducers, styryl diphenylamine derivatives, inhibit growth and metastasis of murine tumor cells in vivo.
    Ohizumi I; Tanemura M; Tsunenari T; Sato K; Kozono T; Kaiho S
    Anticancer Res; 1997; 17(1A):393-400. PubMed ID: 9066683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antineoplastic effect of the pyrimido-pyrimidine derivative: RA 233.
    Biddle W; Montagna RA; Leong SS; Horoszewicz J; Gastpar H; Ambrus JL
    Pathol Biol (Paris); 1984 Jan; 32(1):9-13. PubMed ID: 6701010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 132.